2022 Third Quarter Earnings Conference Call Tuesday, November 8, 2022, 5:00 p.m. ETGlobeNewsWire • 11/01/22
OraSure Technologies Receives $8.6 Million BARDA Contract to Develop 2nd Generation Ebola TestGlobeNewsWire • 09/28/22
OraSure Wins Contract to Supply “Together Take Me Home,” HIV Self-Testing Initiative Sponsored by the Centers for Disease Control and PreventionGlobeNewsWire • 09/20/22
OraSure Partners with Mars Petcare in One of the Largest Ever Microbiome Studies to Evaluate Pet HealthGlobeNewsWire • 09/14/22
OraSure Technologies, Inc. (OSUR) CEO Carrie Manner on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/10/22
OraSure Reports 2Q22 Record Revenue of $80.2 Million Growing 39% Year-Over-YearGlobeNewsWire • 08/09/22
OraSure Technologies to Hold 2022 Second Quarter Earnings Conference Call Tuesday, August 9, 2022, 5:00 p.m. ETGlobeNewsWire • 08/02/22
OraSure's Ongoing Commitment to End the Hepatitis C Epidemic Heats Up at the RacetrackGlobeNewsWire • 07/28/22
OraSure Technologies Launches New Product for Microbiome Researchers to Study DNA and RNAGlobeNewsWire • 07/14/22
OraSure Technologies Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)GlobeNewsWire • 06/08/22
InteliSwab® COVID-19 Rapid Test Selected by Federal Government for Nationwide School TestingGlobeNewsWire • 05/25/22
InteliSwab® COVID-19 Rapid Test Validated to Detect the Omicron BA.2, BA.2.12.1, BA.3 and BA.5 SubvariantsGlobeNewsWire • 05/17/22
OraSure Technologies, Inc. (OSUR) CEO Nancy Gagliano on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 05/11/22
OraSure Technologies (OSUR) Reports Q1 Loss, Tops Revenue EstimatesZacks Investment Research • 05/11/22
OraSure Reports 1Q22 Record Revenue of $67.7 Million; +16% Year-Over-Year With 21% Growth in Non-COVID RevenueGlobeNewsWire • 05/10/22
OraSure Technologies, Inc. 2022 First Quarter Earnings Conference Call Tuesday, May 10, 2022, 5:00 p.m. ETGlobeNewsWire • 05/03/22
OraSure Technologies' Subsidiary DNA Genotek Launches the First Device with De Novo Authorization from the FDA for the Preservation and Stabilization of Microbiome SamplesGlobeNewsWire • 04/07/22
OraSure Technologies' Subsidiary Diversigen Launches Metatranscriptomic Sequencing and Analysis Services for Gut Microbiome SamplesGlobeNewsWire • 03/31/22
OraSure Director Nancy Gagliano Selected to Serve as Interim Chief Executive Officer; Brings Extensive Diagnostics and Healthcare Leadership Experience to RoleGlobeNewsWire • 03/22/22
OraSure Technologies, Inc. (OSUR) CEO Stephen Tang on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 02/24/22
OraSure Technologies Reports 4Q21 Revenue of $63.6 Million; InteliSwab® Production Scales UpGlobeNewsWire • 02/23/22